The Pathogenicity of the M9 Mutant of Semliki Forest Virus in Immune-compromised Mice

References

1. Allner K., Bradish C. J., Fitzgeorge R., Nathanson N. 1974; Modification by sodium auro-thio-malate of the expression of virulence in mice by defined strains of Semliki Forest virus. Journal of General Virology 24:221–228
   [Google Scholar]
2. Atkins G. J. 1983; The avirulent A7 strain of Semliki Forest virus has reduced cytopathogenicity for neuroblastoma cells compared to the virulent L10 strain. Journal of General Virology 64:1401–1404
   [Google Scholar]
3. Atkins G. J., Sheahan B. J. 1982; Semliki Forest virus neurovirulence mutants have altered cytopathogenicityfor central nervous system cells. Infection and Immunity 36:333–341
   [Google Scholar]
4. Barrett P. N., Sheahan B. J., Atkins G. J. 1980; Isolation and preliminary characterization of Semliki Forest virus mutants with altered virulence. Journal of General Virology 49:141–147
   [Google Scholar]
5. Berger M. L. 1980; Humoral and cell-mediated immune mechanisms in the production of pathology in avirulent Semliki Forest virus encephalitis. Infection and Immunity 30:244–253
   [Google Scholar]
6. Blakemore W. F. 1973; Demyelination of the superior cerebellar peduncle in the mouse induced by cuprizone. Journal of the Neurological Sciences 20:63–72
   [Google Scholar]
7. Bradish C. J., Allner K., Fitzgeorge R. 1975a; Immunomodification and the expression of virulence in mice by defined strains of Semliki Forest virus: the effects of cyclophosphamide. Journal of General Virology 28:225–237
   [Google Scholar]
8. Bradish C. J., Allner K., Fitzgeorge R. 1975b; Immunomodification and the expression of virulence in mice by defined strains of Semliki Forest virus: the effects of Myocrisin and 1-asparaginase. Journal of General Virology 28:239–250
   [Google Scholar]
9. Chew-Lim M. 1979; Brain viral persistence and myelin damage in nude mice. Canadian Journal of Comparative Medicine 43:39–43
   [Google Scholar]
10. Dal Canto M. C., Rabinowitz S. G. 1982; Experimental models of virus-induced demyelination of the central nervous system. Annals of Neurology 11:109–127
    [Google Scholar]
11. Fazakerley J. K., Amor S., Webb H. E. 1983; Reconstitution of Semliki Forest virus-infected mice induces immune-mediated pathological changes in the CNS. Clinical and Experimental Immunology 52:115–120
    [Google Scholar]
12. Jagelman S., Suckling A. J., Webb H. E., Bowen E. T. W. 1978; The pathogenesis of avirulent Semliki Forest virus infection in athymic nude mice. Journal of General Virology 41:599–607
    [Google Scholar]
13. Kelly W. R., Blakemore W. F., Jagelman S., Webb H. E. 1982; Demyelination in mice by avirulent Semliki Forest virus. II. An ultrastructural study of focal demyelination in the brain. Neuropathology and Applied Neurobiology 8:43–53
    [Google Scholar]
14. Lampert P. W., Sims J. K., Kniazeff A. 1973; Mechanism of demyelination in JHM virus encephalomyelitis. Electron microscope studies. Acta neuropathologica 24:76–85
    [Google Scholar]
15. Lando Z., Teitelbaum D., Arnon R. 1980; Induction of experimental allergic encephalomyelitis in genetically resistant strains of mice. Nature, London 287:551–553
    [Google Scholar]
16. Lipsky P. E., Ziff M. 1976; Inhibition of antigen and mitogen-induced human lymphocyte proliferation by gold sodium thiomalate. Arthritis and Rheumatism 91:808–812
    [Google Scholar]
17. Mazlo M., Tariska D., Arnon R. 1980; Morphological demonstration of the first phase of polyomavirus replication in oligodendroglia cells of human brain in progressive multifocal leukoencephalopathy (PML). Acta neuropathologica 49:133–144
    [Google Scholar]
18. Mehta S., Webb H. E. 1982; Lysosomal enzyme changes in macrophages from mice given Myocrisin and infected with avirulent Semliki Forest virus. British Journal of Experimental Pathology 63:433–446
    [Google Scholar]
19. Nagashima K., Wege H., Meyermann R., Ter Meulen V. 1978; Coronavirus-induced subacute demyelinating encephalomyelitis in rats: a morphological analysis. Acta neuropathologica 44:63–70
    [Google Scholar]
20. Otu A. A., Russell R. J., White R. G. 1976; Biphasic pattern of activation of the reticuloendothelial system by anaerobic coryneforms in mice. Immunology 32:255–264
    [Google Scholar]
21. Roder J., Dowe A. 1976; The beige mutation in the mouse selectively impairs natural killer cell function. Nature, London 278:451–453
    [Google Scholar]
22. Sheahan B. J., Barrett P. N., Atkins G. J. 1981; Demyelination in mice resulting from infection with a mutant of Semliki Forest virus. Acta neuropathologica 53:129–136
    [Google Scholar]
23. Sheahan B. J., Gates M. C., Caffrey J. F., Atkins G. J. 1983; Oligodendrocyte infection and demyelination produced in mice by the M9 mutant of Semliki Forest virus. Acta neuropathologica 60:257–265
    [Google Scholar]
24. Suckling A. J., Jagelman S., Webb H. E. 1977; Brain lysosomal glycosidase activity in immunosuppressed mice infected with avirulent Semliki Forest virus. Infection and Immunity 15:386–391
    [Google Scholar]
25. Suckling A. J., Pathak S., Jagelman S., Webb H. E. 1978; Virus-associated demyelination. A model using avirulent Semliki Forest virus infection of mice. Journal of the Neurological Sciences 39:147–154
    [Google Scholar]
26. Suckling A. J., Jagelman S., Illavia S. J., Webb H. E. 1980; The effect of mouse strain on the pathogenesis of the encephalitis and demyelination induced by avirulent Semliki Forest virus infections. British Journal of Experimental Pathology 61:241–244
    [Google Scholar]
27. Turk J. L., Parker D. 1982; Effect of cyclophosphamide on immunological control mechanisms. Immunological Reviews 65:99–113
    [Google Scholar]
28. Wisniewski H. M., Lassman H., Brosnan C. F., Mehta P. D., Lidsky A. A., Madrid R. E. 1982; Multiple sclerosis: immunological and experimental aspects. Recent Advances in Clinical Neurology 3:95–124
    [Google Scholar]